Determination of risks for business entities in the sphere of manufacturing medicines in military conditions in Ukraine

Authors

DOI:

https://doi.org/10.15587/2519-4852.2023.289981

Keywords:

risk assessment, pharmaceutical company, drug production, martial law in Ukraine, environmental safety, environmental risk, environmental management system

Abstract

The aim: determination of risks for business entities in the field of production of medicinal products under the conditions of martial law in Ukraine.

Materials and methods. The research materials are the results of a sociological survey in the form of a questionnaire among representatives of the senior management heads of structural units related to the environmental component of business entities' activities in the pharmaceutical production field. Method of sociological survey was used to collect primary information. A questionnaire was conducted, and respondent’s answers were registered using google-forms. The method of comparative analysis and generalization of statistical data was used to process the results.

Results. The study identified, analyzed, and assessed risks for business entities in producing medicinal products under martial law in Ukraine.

Significant risks of the destruction of infrastructure and the occurrence of man-made disasters have been identified. Thus, 10 % of pharmaceutical enterprises received critical damage, which makes it impossible to operate the enterprise until the destructive consequences are eliminated; another 15 % received some damage, but the company's activities are carried out. More than 75 % of enterprises can fully comply with the current licensing conditions (LC) for producing and selling medicinal products under martial law.

How critical risks were assessed: supply of raw materials and materials (logistics problems) (60 %); decrease in demand for the company's products (45 %); termination of gas supply (45 %); power outage (40 %); inflation, rising prices of raw materials and energy resources (35 %); termination of communications (35 %); difficulties in purchasing equipment, consumables, devices (30 %); termination of water supply (30 %); lack of competent personnel (30 %).

In the zone of critical risk at this stage remains the ability and willingness of enterprises to work following the plans of the state environmental policy following the Association Agreement between the EU countries and Ukraine. Respondents admit that the company lacks resources to comply with all requirements (20 %), that environmental aspects of activity are currently irrelevant (25 %), and that there are not enough competent specialists to implement the environmental policy and support the relevant procedures (25 %); that there is not enough informational support from the State (30 %).

Conclusions. In fact, 30 % of pharmaceutical enterprises are located in regions that are currently included in the List of territories where hostilities are (were) being waged or temporarily occupied. In general, Ukrainian business entities in the field of pharmaceutical production remain in the zone of uncertainty and significant risk of man-made disasters, non-fulfilment of requirements regarding production conditions, technological processes and constant quality control of production, non-fulfilment of environmental safety of production due to the direct threat of destruction of infrastructure and supply chains, due to the threat of termination of reliable supply of electricity, gas, water, resources, as well as due to high migration of qualified personnel.

Considering the current state of the economy and the environmental consequences of the war, particularly man-made disasters, the implementation of plans to comply with the state environmental policy and the fulfilment of some requirements of the Association Agreement between the EU and Ukraine is at risk.

In the long term, careful scientifically based planning of the rehabilitation program of the pharmaceutical sector is needed, taking into account the risks of pharmaceutical pollution and the adverse impact of the pharmaceutical industry on the natural environment, in particular through the implementation of environmental management systems (EMS) as part of the overall management system of the enterprise to manage environmental aspects; fulfilment of mandatory legal requirements and voluntary obligations following the goals and environmental policy of the enterprise; and to address issues related to risks and opportunities, especially concerning emergency preparedness and emergency response.

Author Biographies

Victoriia Zhurenko, National University of Pharmacy

Postgraduate Student

Department of Pharmacy Management and Economics

Institute of Advanced Training of Pharmacy Specialists

Viacheslav Lebedynets, National University of Pharmacy

Doctor of Pharmaceutical Sciences, Professor

Department of Pharmacy Management and Economics

Institute of Advanced Training of Pharmacy Specialists

References

  1. Direct damage caused to Ukraine’s infrastructure during the war has reached over $105.5 billion (2022). KSE. Available at: https://kse.ua/about-the-school/news/direct-damage-caused-to-ukraine-s-infrastructure-during-the-war-has-reached-over-105-5-billion/
  2. Report Risks and impacts from attacks on energy infrastructure in Ukraine (2022). Environment and Conflict Alert on Ukraine. PAX. Available at: https://paxvoorvrede.nl/media/download/PAX_Ukraine_energy_infrastructure_FIN.pdf?_gl=1*12v01n1*_ga*MzEyNjEyMTkwLjE2ODMzNTM0MjY.*_ga_0HECE3F7KG*MTY4Mzc0MDA2MS4zLjAuMTY4Mzc0MDA2MS4wLjAuMA
  3. Program of relocation of enterprises. Ministry of Economy of Ukraine. Available at: https://me.gov.ua/Documents/Detail?lang=uk-UA&id=3e766cf9-f3ca-4121-8679-e4853640a99a&title=ProgramaRelokatsiiPidprimstv
  4. Testa, F., Heras-Saizarbitoria, I., Daddi, T., Boiral, O., Iraldo, F. (2016). Public regulatory relief and the adoption of environmental management systems: a European survey. Journal of Environmental Planning and Management, 59 (12), 2231–2250. doi: https://doi.org/10.1080/09640568.2016.1139491
  5. Papagiannakis, G., Voudouris, I., Lioukas, S., Kassinis, G. (2019). Environmental management systems and environmental product innovation: The role of stakeholder engagement. Business Strategy and the Environment, 28 (6), 939–950. doi: https://doi.org/10.1002/bse.2293
  6. Fanasch, P. (2018). Survival of the fittest: The impact of eco‐certification and reputation on firm performance. Business Strategy and the Environment, 28 (4), 611–628. doi: https://doi.org/10.1002/bse.2268
  7. Wagner, M. (2019). Global governance in new public environmental management: An international and intertemporal comparison of voluntary standards’ impacts. Business Strategy and the Environment, 29 (3), 1056–1073. doi: https://doi.org/10.1002/bse.2417
  8. Herghiligiu, I. V., Robu, I.-B., Pislaru, M., Vilcu, A., Asandului, A. L., Avasilcăi, S., Balan, C. (2019). Sustainable Environmental Management System Integration and Business Performance: A Balance Assessment Approach Using Fuzzy Logic. Sustainability, 11 (19), 5311. doi: https://doi.org/10.3390/su11195311
  9. Nowicki, P., Ćwiklicki, M., Kafel, P., Wojnarowska, M. (2021). Credibility of certified environmental management systems: Results from focus group interviews. Environmental Impact Assessment Review, 88, 106556. doi: https://doi.org/10.1016/j.eiar.2021.106556
  10. Zhurenko, V. V., Lebedynets, V. O. (2022). Characteristics of development and dissemination of environmental management systems in the area of production of medicines in Ukraine. Česká a Slovenská Farmacie, 71 (5), 200–213. doi: https://doi.org/10.5817/csf2022-5-200
  11. State Service of Ukraine for Medicinal Products and Drug Control. Report On the results of activities in 2022 (2023). Kyiv. Available at: https://www.dls.gov.ua/wp-content/uploads/2023/02/%D0%9F%D1%83%D0%B1%D0%BB%D1%96%D1%87%D0%BD%D0%B8%D0%B9-%D0%B7%D0%B2%D1%96%D1%82-%D0%93%D0%BE%D0%BB%D0%BE%D0%B2%D0%B8-%D0%B7%D0%B0-2022.pdf
  12. List of territories on which hostilities are (were) conducted or temporarily occupied by the Russian Federation (2022). Ministry of Reintegration No 309. 22.12.2022. Available at: https://ips.ligazakon.net/document/view/re39004?an=1
  13. Sobkevich, O. V., Shevchenko, A. V., Rusan, V. M., Zhurakovska, L. A.; Zhalil, Ya A. (Ed.) (2023). Priorities of ensuring the stability of industry and the agricultural sector of the economy of Ukraine in conditions of full-scale war. Kyiv: NISS, 49. doi: https://doi.org/10.53679/niss-analytrep.2023.04
  14. “Nishcho ne obmezhuie optymizm” Osnovni ekonomichni tendentsiï ta ochikuvannia u travni 2023 za rezultatamy «Novoho shchomisiachnoho opytuvannia pidpryiemstv», #NRES (2023). The Institute for economic research and policy consulting. Available at: http://www.ier.com.ua/ua/institute/news?pid=7205
  15. Bryf-analiz rozdribnoho farmrynku: poperedni pidsumky 2022 r. Available at: https://www.apteka.ua/article/655830
  16. Pro vnesennia zmin do postanovy Kabinetu Ministriv Ukrainy vid 9 zhovtnia 2020 r. No. 1109 (2022). Postanova KMU No. 1384. 16.12.2022. Available at: https://zakon.rada.gov.ua/laws/show/1384-2022-%D0%BF#Text
  17. Farmvyrobnyky mozhut skorotyty vyrobnytstvo cherez problemy z enerhopostachanniam, prosiat urehuliuvaty vidkliuchennia farmzavodiv (2022). Available at: https://interfax.com.ua/news/pharmacy/870044.html
  18. Ukraine refugee situation (2023). Operational data portal. Available at: https://data.unhcr.org/en/situations/ukraine
  19. Ukrainskyi tsentr otsiniuvannia yakosti osvity. Available at: https://testportal.gov.ua/
  20. Wess, R. A. (2020). Update of EMA’s Guideline on the Environmental Risk Assessment (ERA) of Medicinal Products for Human Use. Therapeutic Innovation & Regulatory Science, 55 (2), 309–323. doi: https://doi.org/10.1007/s43441-020-00216-1
  21. Pinho-Gomes, A.-C., Yoo, S.-H., Allen, A., Maiden, H., Shah, K., & Toolan, M. (2022). Incorporating environmental and sustainability considerations into health technology assessment and clinical and public health guidelines: a scoping review. International Journal of Technology Assessment in Health Care, 38 (1). doi: https://doi.org/10.1017/s0266462322003282
  22. Firth, I., Hitch, J., Henderson, N., Cookson, G. (2023). Moving towards a more environmentally sustainable pharmaceutical industry: recommendations for industry and the transition to green HTA. Expert Review of Pharmacoeconomics & Outcomes Research, 23 (6), 591–595. doi: https://doi.org/10.1080/14737167.2023.2214730
  23. Linder, E., Villén, J., Nekoro, M., Wettermark, B., Sporrong, S. K. (2023). Stakeholders’ perspectives and use of web-based knowledge support for environmental information on pharmaceuticals. Exploratory Research in Clinical and Social Pharmacy, 11, 100303. doi: https://doi.org/10.1016/j.rcsop.2023.100303
  24. Kittery, A., Miettinen, M. (2022). Environmental considerations in the European Union’s pharmaceuticals legislation: Key instruments and their challenges in addressing global manufacturing supply chains. Review of European, Comparative & International Environmental Law, 32 (1), 77–91. doi: https://doi.org/10.1111/reel.12488
  25. Firth, I., Hitch, J., Henderson, N., Firth, I. (2022). Supporting the Era of Green Pharmaceuticals in the UK. 2022. Available at: https://www.ohe.org/publications/supporting-the-era-of-green-pharmaceuticals-in-the-uk/
  26. Emara, Y., Siegert, M.-W., Lehmann, A., Finkbeiner, M. (2018). Life Cycle Management in the Pharmaceutical Industry Using an Applicable and Robust LCA-Based Environmental Sustainability Assessment Approach. Designing Sustainable Technologies, Products and Policies, 79–88. doi: https://doi.org/10.1007/978-3-319-66981-6_9
  27. Report on implementation of the Association agreement between Ukraine and the European Union in 2022 (2023). Available at: https://eu-ua.kmu.gov.ua/zvity-pro-vykonannia-uhody-pro-asotsiatsiiu
Determination of risks for business entities in the sphere of manufacturing medicines in military conditions in Ukraine

Downloads

Published

2023-10-31

How to Cite

Zhurenko, V., & Lebedynets, V. (2023). Determination of risks for business entities in the sphere of manufacturing medicines in military conditions in Ukraine. ScienceRise: Pharmaceutical Science, (5(45), 32–43. https://doi.org/10.15587/2519-4852.2023.289981

Issue

Section

Pharmaceutical Science